Clinical Trials Happening
  Participants welcome
Donate to FRAXA
  You can help us find a cure
What is Fragile X?
Fragile X is the most common inherited cause of mental impairment and the most common known cause of autism.
About FRAXA
FRAXA is a 501c3 nonprofit run by parents. Our mission: to find treatments and a cure for Fragile X. FRAXA has funded over $22 million in research.
Visit our Blog
  families, researchers, trials
Email Signup
  Get the latest FRAXA News!

March 15, 2013

Research Grant Opportunities for Canadian scientists
Grants of $500,000 per year for five years to be funded by BrainCanada and the Azrieli Foundation

read more >

February 05, 2013

Lovastatin for Fragile X?
High-profile publication by FRAXA-funded team at MIT, led by Dr. Mark Bear, suggests an available medication may treat Fragile X.

read more >

February 01, 2013

FRAXA Finances - a look at the numbers over the past 3 years
For 2013, FRAXA anticipates funding at least $1.2 million in research. Applications from scientists have just arrived and are under review; we'll announce the new projects on April 1.

read more >

November 27, 2012

FRAXA Progress and Future Plans
It's official: Fragile X is now the hottest research topic in all of neuroscience!

read more >